FOR RESEARCH USE ONLY
The content provided in this article is for educational and informational purposes only and is based on published scientific literature. The compounds discussed are not approved by the FDA for human or veterinary use. They are strictly intended for laboratory research and in vitro experimentation. Validated Peptides does not endorse or encourage the use of these products outside of a controlled research setting.
Melanotan 1 and Melanotan 2 are both synthetic analogues of alpha-melanocyte-stimulating hormone (alpha-MSH). They were developed in the same research program at the University of Arizona but solved the same problem in different ways. One is long and linear. The other is short, cyclic, and more constrained.
This article compares their structures, the two key substitutions they share, the engineering behind the ring in Melanotan 2, the receptors they target, and how a real Melanotan II lot is documented. Everything stays at the level of structure, history, and laboratory verification.
Research Snapshot
The points above are expanded in the sections below with the original citations.
Introduction
Melanotan 1 and Melanotan 2 are often spoken about as if they were two versions of the same thing. They are better understood as two different design answers to the same question: how do you take the natural hormone alpha-MSH and make it more stable and more potent as a research tool?
Melanotan 1 keeps the full 13-amino-acid sequence of the hormone and makes two substitutions. Melanotan 2 keeps only the core message (positions 4–10), makes the same two substitutions, drops the flanking residues, and locks the core into a ring. Those choices explain nearly everything that differs between them. Validated Peptides supplies Melanotan II; Melanotan I is described here for comparison only.
Melanotan 1 vs Melanotan 2 at a Glance
| Melanotan 1 | Melanotan 2 | |
|---|---|---|
| Based on | Full alpha-MSH (positions 1–13) | Alpha-MSH positions 4–10 |
| Length | 13 amino acids | 7 amino acids |
| Shape | Linear | Cyclic (lactam bridge) |
| Key substitutions | Nle⁴, D-Phe⁷ | Nle⁴, D-Phe⁷ + ring (Asp⁵–Lys¹⁰) |
| Sequence | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ | Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-NH₂ |
| First reported | 1980 | 1989 |
| Sold by Validated Peptides | No | Yes (10 mg vial) |
For the Melanotan II we sell, the molecular formula is C₅₀H₆₉N₁₅O₉ and the molecular weight is 1,024.2 g/mol. These match the PubChem entry (CID 92432) and the current Certificate of Analysis.
How to Read the Sequences
The compact notation used for both peptides is worth decoding because the important differences live in the details.
- Ac- and -NH₂: Acetyl cap on the N-terminus and amide on the C-terminus. Both peptides (and natural alpha-MSH) carry these.
- Nle at position 4: Replaces methionine in the natural hormone.
- D-Phe at position 7: The D-amino acid version.
- cyclo( ): The residues inside are joined by a side-chain lactam bridge, forming a ring.
- Subscript 4-10: Only those positions of the original hormone are present.
The Starting Point: Alpha-MSH
Alpha-MSH is a 13-amino-acid peptide with the sequence Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂. It is processed from a larger precursor protein called proopiomelanocortin (POMC). In research, the natural peptide has two practical drawbacks: it is rapidly degraded by enzymes and its activity is short-lived. Both Melanotan peptides were designed to overcome those limitations.
The Two Changes They Share
Both analogues carry the same two substitutions relative to alpha-MSH numbering.
Norleucine at position 4
The fourth residue in natural alpha-MSH is methionine. Both Melanotan peptides replace it with norleucine (Nle). This change alone already improved stability and duration of action in early studies.
D-phenylalanine at position 7
Position 7 is phenylalanine in the natural hormone. Both analogues use the D (mirror-image) form. This substitution was discovered after researchers noticed that partial conversion of certain residues to their D-forms during heat-alkali treatment produced a peptide that was far more resistant to serum enzymes and 26 times more potent than alpha-MSH in a mouse melanoma adenylate cyclase assay (Sawyer et al., 1980). That molecule is Melanotan 1.
What Makes Melanotan 2 Different: The Ring
The 1989 work took the design one step further. Using molecular dynamics and earlier structure-activity data, researchers created cyclic lactam analogues of shorter fragments of alpha-MSH. They varied the ring size by linking an acidic residue (Asp or Glu) at position 5 to a basic residue (Lys) at position 10.
The analogues with a 23-membered ring proved the most potent — roughly 90–100 times alpha-MSH in a lizard skin bioassay — and showed markedly prolonged activity. The specific 4–10 cyclic analogue with that ring size became Melanotan 2: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-NH₂.
Why Linear vs Cyclic Matters
A linear peptide can adopt many conformations in solution. Closing it into a ring reduces the number of possible shapes. The design hypothesis was that constraining the core of alpha-MSH into a conformation closer to the one it adopts when bound to its receptor would increase both potency and stability. The experimental results across different ring sizes supported that idea.
A direct comparison in a 1989 study showed the cyclic 4–10 analogue had greater potency, longer duration, and better resistance to proteolytic enzymes than the corresponding linear version.
The Receptors Both Act On
Both peptides act on the melanocortin receptor family — five related G-protein-coupled receptors (MC1R through MC5R). The natural ligands for these receptors all contain the conserved tetrapeptide sequence His-Phe-Arg-Trp. Because every receptor in the family recognizes that same core, designing a truly selective ligand has been difficult.
Melanotan 2 later served as a scaffold for further modifications that produced more selective ligands for individual receptor subtypes, including MC3R and MC4R.
Verification
For a small cyclic peptide, the first thing to examine on a Certificate of Analysis is the HPLC purity, because an incompletely closed or incorrectly closed ring produces a closely related impurity. Validated Peptides publishes the current independent laboratory report for Melanotan II on the product page and in the COA library. The most recent test (February 20, 2026) shows 99.822% purity by HPLC.
Our guides to how to read a peptide COA and how to verify a peptide COA walk through every line of a report and how to confirm it directly with the testing laboratory.
What to Check When Sourcing Melanotan II
Because the same molecule is sold under several names (Melanotan II, MT-2, MT-II), the first check is that the listing actually describes the cyclic heptapeptide:
- The sequence is given with the ring clearly indicated: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-NH₂.
- The reported molecular weight (1,024.2 g/mol) and formula (C₅₀H₆₉N₁₅O₉) match the cyclic structure.
- An independent HPLC report from an accredited laboratory is provided and can be verified.
- The listing does not confuse Melanotan II with the longer linear peptide Melanotan I.
Storing Melanotan II in the Lab
Melanotan II ships as a lyophilized (freeze-dried) white powder. Standard laboratory guidance is to store the powder in a cool, dry place protected from light, preferably refrigerated at 2–8 °C. Repeated freeze-thaw cycles should be avoided. When a protocol calls for a working solution, reconstitute with sterile water or bacteriostatic water.
Where the Two Sit in Melanocortin Research
Melanotan 1 demonstrated that two strategic substitutions could turn the full-length hormone into a stable, potent research tool. Melanotan 2 showed that an even shorter fragment, properly constrained in a ring of the right size, could achieve similar or better results. Together they represent two milestones in the systematic refinement of alpha-MSH analogues for laboratory use.
Melanotan II is also structurally related to PT-141 (bremelanotide). The difference between those two molecules is covered in our article Melanotan II vs PT-141.
Frequently Asked Questions
What is the main structural difference between Melanotan 1 and Melanotan 2?
Length and shape. Melanotan 1 is a linear 13-amino-acid peptide. Melanotan 2 is a 7-amino-acid peptide cyclized by a lactam bridge. The ring constrains the molecule into fewer conformations, which contributed to its potency and stability in the original studies.
Does Validated Peptides sell Melanotan 1?
No. We supply Melanotan II (the cyclic version) as a research-grade 10 mg vial with independent third-party testing. Melanotan 1 is discussed only for comparison.
How pure is your Melanotan II?
The current independent laboratory report shows 99.822% purity by HPLC (tested February 20, 2026). The full COA is published on the product page and can be verified directly with the laboratory.
References
- Sawyer TK, et al. (1980). 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA, 77(10):5754-5758. DOI: 10.1073/pnas.77.10.5754
- Al-Obeidi F, et al. (1989). Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem, 32(12):2555-2561. DOI: 10.1021/jm00132a010
- Hadley ME, et al. (1989). Linear and cyclic alpha-melanotropin [4-10]-fragment analogues that exhibit superpotency and residual activity. Pigment Cell Res, 2(6):478-484. DOI: 10.1111/j.1600-0749.1989.tb00242.x
- Cai M, Hruby VJ (2016). The melanocortin receptor system: a target for multiple degenerative diseases. Curr Protein Pept Sci, 17(5):488-496. DOI: 10.2174/1389203717666160226145330
- National Center for Biotechnology Information. PubChem Compound Summary for CID 92432, melanotan-II. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/92432
All compounds discussed are for laboratory research use only and are not approved for human or veterinary use.



